Sandra Soo Jin Lee

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi Race, distributive justice and the promise of pharmacogenomics: ethical considerations
    Sandra Soo Jin Lee
    Center for Biomedical Ethics, Stanford University Medical School and the Department of Cultural and Social Anthropology, Stanford University, Stanford, California 94304 1703, USA
    Am J Pharmacogenomics 3:385-92. 2003
  2. ncbi The ethics of characterizing difference: guiding principles on using racial categories in human genetics
    Sandra Soo-Jin Lee
    Genome Biol 9:404. 2008
  3. ncbi Secondary uses and the governance of de-identified data: lessons from the human genome diversity panel
    Stephanie M Fullerton
    Department of Bioethics and Humanities, University of Washington School of Medicine, Seattle, 98195, USA
    BMC Med Ethics 12:16. 2011
  4. ncbi Racializing drug design: implications of pharmacogenomics for health disparities
    Sandra Soo Jin Lee
    Stanford Center for Biomedical Ethics, Stanford University, Palo Alto, CA 94304, USA
    Am J Public Health 95:2133-8. 2005
  5. ncbi The ethical implications of stratifying by race in pharmacogenomics
    S S J Lee
    Stanford Center for Biomedical Ethics, Stanford University School of Medicine, Palo Alto, California, USA
    Clin Pharmacol Ther 81:122-5. 2007
  6. ncbi Pharmacogenomics and the challenge of health disparities
    S S Lee
    Stanford Center for Biomedical Ethics, Stanford University Medical School, Palo Alto, California 94304 1703, USA
    Public Health Genomics 12:170-9. 2009
  7. ncbi Research 2.0: social networking and direct-to-consumer (DTC) genomics
    Sandra Soo Jin Lee
    Stanford Center for Biomedical Ethics, Stanford University Medical School, Palo Alto, CA 94304, USA
    Am J Bioeth 9:35-44. 2009
  8. ncbi Genetic research and health disparities
    Pamela Sankar
    Center for Bioethics, School of Medicine, University of Pennsylvania, Philadelphia 19104 3308, USA
    JAMA 291:2985-9. 2004

Detail Information

Publications8

  1. ncbi Race, distributive justice and the promise of pharmacogenomics: ethical considerations
    Sandra Soo Jin Lee
    Center for Biomedical Ethics, Stanford University Medical School and the Department of Cultural and Social Anthropology, Stanford University, Stanford, California 94304 1703, USA
    Am J Pharmacogenomics 3:385-92. 2003
    ..As the field surges ahead, it is critical to examine the use of race in pharmacogenomics research and its attendant benefits and potential harm to individuals and groups...
  2. ncbi The ethics of characterizing difference: guiding principles on using racial categories in human genetics
    Sandra Soo-Jin Lee
    Genome Biol 9:404. 2008
    ..We are a multidisciplinary group of Stanford faculty who propose ten principles to guide the use of racial and ethnic categories when characterizing group differences in research into human genetic variation...
  3. ncbi Secondary uses and the governance of de-identified data: lessons from the human genome diversity panel
    Stephanie M Fullerton
    Department of Bioethics and Humanities, University of Washington School of Medicine, Seattle, 98195, USA
    BMC Med Ethics 12:16. 2011
    ....
  4. ncbi Racializing drug design: implications of pharmacogenomics for health disparities
    Sandra Soo Jin Lee
    Stanford Center for Biomedical Ethics, Stanford University, Palo Alto, CA 94304, USA
    Am J Public Health 95:2133-8. 2005
    ..I argue that public investment in pharmacogenomics requires careful consideration of current inequities in health status and social and ethical concerns over reifying race and issues of distributive justice...
  5. ncbi The ethical implications of stratifying by race in pharmacogenomics
    S S J Lee
    Stanford Center for Biomedical Ethics, Stanford University School of Medicine, Palo Alto, California, USA
    Clin Pharmacol Ther 81:122-5. 2007
    ....
  6. ncbi Pharmacogenomics and the challenge of health disparities
    S S Lee
    Stanford Center for Biomedical Ethics, Stanford University Medical School, Palo Alto, California 94304 1703, USA
    Public Health Genomics 12:170-9. 2009
    ....
  7. ncbi Research 2.0: social networking and direct-to-consumer (DTC) genomics
    Sandra Soo Jin Lee
    Stanford Center for Biomedical Ethics, Stanford University Medical School, Palo Alto, CA 94304, USA
    Am J Bioeth 9:35-44. 2009
    ..Ethical issues related to the reframing of DTC personal genomic consumers as advocates and research subjects and the creation of new social formations around health research may be identified through social network analysis...
  8. ncbi Genetic research and health disparities
    Pamela Sankar
    Center for Bioethics, School of Medicine, University of Pennsylvania, Philadelphia 19104 3308, USA
    JAMA 291:2985-9. 2004
    ....